Bone densitometry firm Norland Medical Systems of White Plains, NY, published its 1998 financial results this month, posting revenue for the fourth quarter (end-December) of $3.3 million, compared with $5.7 million in 1997. The net loss for the
Bone densitometry firm Norland Medical Systems of White Plains, NY, published its 1998 financial results this month, posting revenue for the fourth quarter (end-December) of $3.3 million, compared with $5.7 million in 1997. The net loss for the quarter was $4.3 million, compared with $2.8 million the previous year. The companys fiscal 1998 revenues fell to $14.4 million, down from 1997s $20.5 million. The net loss for the year was $9.7 million, compared with $18.6 million the year before.
The company attributed its decreased revenues to debt and unresolved litigation related to the acquisition of its manufacturing partner, Norland Corp. The distractions affected the companys sales efforts, according to Reynald Bonmati, chair and CEO. But on Dec. 31, the firm signed an agreement to settle the lawsuit, a move that contributed to the reduction of the companys debt by about 66%.
In other news, Norland also this month began shipping Excell DXA, an axial scanner that is the first table scanner in the U.S. listed below $30,000. The company introduced the unit at last years Radiological Society of North America meeting.
New Study Assesses Benefits of High-Resolution Photon-Counting for Computed Tomography Angiography
October 10th 2024Researchers found that ultra-high resolution photon-counting significantly enhanced visualization of small vessels and facilitated improved reduction of blooming artifacts for head and neck computed tomography angiography (CTA) scans.
Multicenter Study Identifies Key Factors Associated with Mammogram-Occult Ipsilateral Breast Cancer
October 9th 2024A symptomatic first breast cancer diagnosis, prevailing breast density at a second breast cancer diagnosis and trabecular thickening on surveillance mammography were linked to mammogram-occult ipsilateral breast cancer, according to new research.